Selective in vivo dosimetry in radiotherapy using P-type semiconductor diodes: a reliable quality assurance procedure.

Since 1994, our center has conducted entrance dose measurements on selected patients receiving 6MV x-ray therapy by utilizing a commercial set of p-type semiconductor diodes. We report on three years results representing 386 patients having 1005 measurements and the usefulness of such a system in a radiotherapy department. The 386 patients represent approximately 20% of our total radical treatments. Minimal disruption to patient treatment was achieved. Measurements showed an average variation from expected dose of 0.5% +/- 2.2%. Specific treatment site groups were investigated. Our results show that in vivo dosimetry on a selected group of patients is an effective method of providing an independent verification of dose delivery accuracy.